Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 2, 2013, Pages 181-192

  Stillhart, Cordula ^a,b   Cavegn, Martin ^b   Kuentz, Martin ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

aqueous dilution; in vitro screening; precipitation; supersaturation; surfactant co solvent systems

Indexed keywords

ALCOHOL; FENOFIBRATE; SOLVENT; SURFACTANT;

ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SOLUBILITY; IN VITRO STUDY; LIGHT SCATTERING; MICELLE; MICELLIZATION; PARTICLE SIZE; PRECIPITATION; RAMAN SPECTROMETRY; SOLUBILIZATION; TEMPERATURE SENSITIVITY; X RAY DIFFRACTION;

CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FENOFIBRATE; INDICATOR DILUTION TECHNIQUES; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SOLVENTS; SPECTRUM ANALYSIS, RAMAN; SURFACE-ACTIVE AGENTS; WATER; X-RAY DIFFRACTION;

EID: 84871715919     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01586.x     Document Type: Article

References (33)

1. Gursoy RN, Benita S,. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58: 173-182.
2. Pouton CW,. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000; 11: 93-98.
3. Dahan A, Hoffman A,. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci 2005; 24: 381-388.
4. O'Driscoll CM,. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002; 15: 405-415.
5. Pouton CW,. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006; 29: 278-287.
6. Moulik SP, Paul BK,. Structure, dynamics and transport properties of microemulsions. Adv Colloid Interfac Sci 1998; 78: 99-195.
7. Alany RG, et al,. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 2001; 27: 31-38.
8. Fanun M,. Properties of microemulsions based on mixed nonionic surfactants and mixed oils. J Mol Liq 2009; 150: 25-32.
9. Fanun M,. Properties of microemulsions with sugar surfactants and peppermint oil. Colloid Polym Sci 2009; 287: 899-910.
10. Abdalla A, Mäder K,. ESR studies on the influence of physiological dissolution and digestion media on the lipid phase characteristics of SEDDS and SEDDS pellets. Int J Pharm 2009; 367: 29-36.
11. Kuentz M, Cavegn M,. Critical concentrations in the dilution of oral self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 2010; 36: 531-538.
12. Hickey S, et al,. Analysis of phase diagram and microstructural transitions in an ethyl oleate/water/Tween 80/Span 20 microemulsion system using high-resolution ultrasonic spectroscopy. Int J Pharm 2010; 388: 213-222.
13. Shah RB, et al,. Quality by design: Characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm 2007; 341: 189-194.
14. Mohsin K, et al,. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci 2009; 98: 3582-3595.
15. Brouwers J, et al,. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci 2009; 98: 2549-2572.
16. Warren DB, et al,. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis of utility. J Drug Target 2010; 18: 704-731.
17. Munoz A, et al,. Micronized fenofibrate. Atherosclerosis 1994; 110: 45-48.
18. Kashchiev D, van Rosmalen GM,. Review: nucleation in solutions revisited. Cryst Res Technol 2003; 38: 555-574.
19. Gao P, et al,. Characterization and optimization of AMG 517 supersaturable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci 2009; 98: 516-528.
20. Ruf A, et al,. Modeling and experimental analysis of PSD measurements through FBRM. Part Part Syst Char 2000; 17: 167-179.
21. Yalkowsky SH,. Solubilization by cosolvents. In:, Yalkowsky SH, ed. Solubility and Solubilization in Aqueous Media. Washington: American Chemical Society, 1999: 180-235.
22. Yalkowsky SH,. Solubilization by surfactants. In:, Yalkowsky SH, ed. Solubility and Solubilization in Aqueous Media. Washington: American Chemical Society, 1999: 236-320.
23. Ran Y, et al,. Solubilization of cyclosporin A. AAPS PharmSciTech 2001; 2: E2.
24. Sarvazyan AP,. Ultrasonic velocimetry of biological compounds. Annu Rev Biophys Biol 1991; 20: 321-342.
25. Urick RJ,. A sound velocity method for determining the compressibility of finely divided substances. J Appl Phys 1947; 18: 983-987.
26. Wood AB,. A Textbook of Sound. London: G. Bell, 1941.
27. Ditner C, et al,. A systematic dilution study of self-microemulsifying drug delivery systems in artificial intestinal fluid using dynamic laser light backscattering. Drug Dev Ind Pharm 2009; 35: 199-208.
28. Stillhart C, Kuentz M,. Comparison of high-resolution ultrasonic resonator technology and Raman spectroscopy as novel process analytical tools for drug quantification in self-emulsifying drug delivery systems. J Pharmaceut Biomed 2012; 59: 29-37.
29. Bevernage J, et al,. Drug precipitation-permeation interplay: supersaturation in an absorptive environment. Eur J Pharm Biopharm 2012. doi: 10.1016/j.ejpb.2012.07.009.
30. Cuiné JF, et al,. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci 2008; 97: 995-1012.
31. Psachoulias D, et al,. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults. Pharm Res 2011; 28: 3145-3158.
32. Sassene PJ, et al,. Precipitation of a poorly water soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. J Pharm Sci 2010; 99: 4982-4991.
33. Kuentz M,. Lipid-based formulations for oral delivery of lipophilic drugs. Drug Discov Today 2012; 9: e97-e104.